|
Key
Products and Technology
| STS
structure
time shift
homogenous complexes of Lanthanides & heavy metals
MTL
magnetic
target liposomes
for radiation therapy,
drug targeting, imaging and diagnosis (PXT, NCT, MDT, MRI, PET)
PFF
, PFC
poly-Ferrofluids
(30-300 nm)
with large magnetic
moment for medical applications (MDT, PXT, NCT, MRI)
UMB
upright
magnetic balance
device
for
characterization of magnetic nanoparticles
|
|
Disclaimer
The
liable impressum and disclaimer is presented at Nanovel_disclaimer
 FerroMed
is a company for production and sales of biomedical products and
nanotechnology, under foundation. This covers also the
metal products of our Feromed
biometalics division. Sales and company is currently organized by Nanovel Ltd.
& Co KG. Orders may be done by email to sales@nanovel.de or sales@ferromed.de
, according to our terms of business and catalogue. For questions
send an email to info@ferromed.de
please.
 Impressum:
(Anbieterkennzeichnung nach §6 TDG)
Nanovel Ltd.
& Co KG, in the following entitled as 'Nanovel',
is a company for production and sales of innovative biomedical products and
bio-nanotechnology.
Business data and responsibility
for the Internet domain and contents, according to the german
laws: TDG, §6, luKDG, MDStV, §6 II:
Nanovel
Ltd. & Co KG
Naheweinstr. 222
D-55450 Langenlonsheim
Tel.:
+49 1803 551833458 (phone, fax, voice-box); +49 175 6563336
Fax.:
+49 1803 551833458
Internet - WEB : www.nanovel.de
,entry: www.nanovel.eu
eMail:
info@nanovel.de
Handelsregister:
Bad Kreuznach, HRA 20125
Umsatzsteueridentifikationsnummer: DE252206136
Steuernummer:
06 205 056 2
Represented by the Nanovel Technology Ltd., registered in
England and Wales, No. 06059076, director, and 'Geschäftsführer':
PD. Dr. Thomas Nawroth
Links
: FerroMed and
Feromed are
not responsible for the contents of any of the links enclosed in
the WEB-sites www.ferromed.de
nor www.feromed.de . The responsibility
is exclusively due to the owners of the refered WEB-sites.
Trade
marks and protected designs: FerroMed, Feromed and Nanovist
are applied for trademarks. The graphic logos of FerroMed, Feromed and
MPSD are applied for protection.
The mark MPSD
is in commercial use since 1992 for information services
in research and development (R&D), science organizations
universities, research centers, MPI's),and industry; and thus protected
of foreign trade mark applications (elder right of an existing mark,
according to EU / oami). For more information visit www.mpsd.de
or mail to info@mpsd.de .
Contact :
You may contact us at:
-
email to info@ferromed.de ....
For general information see our Information
server : www.mpsd.de
Responsible and
design
: Priv.Doz. Dr. Thomas Nawroth, nawroth@ferromed.de
and www.mpsd.de
|
Events,
Conferences
DPhG 2007
10.-13.10.2005 Erlangen
Target Nanoparticles
for
cancer therapy
presentation
using nanoproducts from Nanovel and FerroMed
SNI 2006
10.2006 Hamburg
Target Nanoparticles
for
cancer therapy
3
presentations
using products from Nanovel and FerroMed
6th
Ferrofluid workshop
20.-22.
7.2005 Saarbruecken
Magnetic
target liposome (MTL)
presentation
of concept and results of three ML-types for cancer therapy
and diagnosis
(handout
as PDF-file)
|
